Profile
Corporate information
Official name
Boehringer Ingelheim Venture Fund GmbH
Also known as
BIVF
Registration country
Investment activity status
Active investor
Fund terms
Investments
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
![]() |
NBE-Therapeutics AG Biotech company focused on developing antibody-based treatments for cancer patients. |
Switzerland | 8 Nov 2016 | Series B Round participant. Active |